ijms-logo

Journal Browser

Journal Browser

New Challenges of Parkinson’s Disease, 2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 December 2025 | Viewed by 457

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Molecular Medicine and Biotechnology, IRCCS Fondazione Don Carlo Gnocchi, Via Capecelatro 66, 20148 Milan, Italy
Interests: genetics; autism; neurodegenerative disorders; Alzheimer; multiple sclerosis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121 Milano, Italy
Interests: extracellular vesicles; neurodegenerative disorders; molecular genetics; Alzheimer; multiple sclerosis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue will be supervised by Dr. Cristina Agliardi and Dr. Franca R. Guerini, assisted by our Topical Advisory Panel Member Dr. Peter Antony Barbuti.

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder characterized by both motor and non-motor symptoms including sleep and mood disorders and cognitive, sensory and autonomic dysfunctions. The etiology of the disease in most patients is unknown, but different genetic causes have been identified. Moreover, the existing treatments are limited in effect and mainly address the symptoms rather than the cause or the progressive course. Improving our understanding of what causes the complexity and diversity of PD is a major challenge for researchers. Tools are needed to group people with similar types of PD so that individuals who are most likely to benefit from clinical trials can be studied and their responses to treatment can be compared in a meaningful way. The aim of this Special Issue is to collect the latest research on PD in terms of:

  • Etiology understanding: genetic and environmental influences, mitochondrial dysfunction, protein aggregation, misfolding and cell-to-cell spreading mechanisms, neuroinflammation, etc.;
  • New biomarkers discovery: imaging scans (MRI, CT), extracellular vesicles in biofluids, genetics, epigenetics and microbiome analysis;
  • Novel disease-modifying treatments: gene therapy, deep brain stimulation and animal models;
  • Strategies that provide symptoms relief: diet, exercise, rehabilitation and stress reduction.

We welcome both original research and review articles.

Dr. Franca Rosa Rosa Guerini
Dr. Cristina Agliardi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Parkinson’s disease
  • neurodegeneration
  • synuclein
  • diagnosis
  • genetics
  • epigenetics
  • extracellular vesicles
  • biomarkers
  • treatments
  • rehabilitation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

27 pages, 6094 KB  
Article
p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson’s Disease
by Tatiana S. Usenko, Alena E. Kopytova, Artem D. Izyumchenko, Darya G. Kulabukhova, Artemiy S. Silantyev, Victoria D. Kazakova, Katerina S. Basharova, Anastasia I. Bezrukova, Luiza A. Garaeva, Evgeny B. Pichkur, Alexandra V. Artynyuk, Irina V. Miliukhina, Alla A. Timofeeva, Valentina V. Miroshnikova, Stanislav N. Naryzhny, Anton K. Emelyanov, Natalya B. Zakharzhevskaya, Andrey L. Konevega, Tatiana A. Shtam and Sofya N. Pchelina
Int. J. Mol. Sci. 2025, 26(18), 9152; https://doi.org/10.3390/ijms26189152 - 19 Sep 2025
Viewed by 148
Abstract
Parkinson’s disease, associated with mutations in the GBA1 gene (GBA1-PD), is the most common genetic form of Parkinson’s disease (PD), marked by clinical heterogeneity influenced by mutation type. Extracellular vesicles (EVs), key mediators of intercellular communication, are implicated in PD pathogenesis through the [...] Read more.
Parkinson’s disease, associated with mutations in the GBA1 gene (GBA1-PD), is the most common genetic form of Parkinson’s disease (PD), marked by clinical heterogeneity influenced by mutation type. Extracellular vesicles (EVs), key mediators of intercellular communication, are implicated in PD pathogenesis through the transport of pathological proteins and lipids. In this study, we analyzed blood plasma-derived EVs from GBA1-PD patients carrying p.N370S and p.L444P mutations and from healthy controls using cryo-electron microscopy, lipidomics, and proteomics. EVs from GBA1-PD patients were significantly larger than those from controls, with the largest size and most multilayered vesicles observed in p.N370S carriers. Lipidomic profiling identified 237 lipid species; of these, 186 lipids were altered in p.N370S and 24 in p.L444P versus controls. Mutation carriers showed distinct lipid signatures, with p.L444P samples enriched predominantly in sphingolipids, while p.N370S carriers exhibited more extensive lipid remodeling across multiple classes, including triglycerides, cholesteryl esters, and phospholipids. Notably, Cer 23:0 was elevated across all GBA1-PD groups. Proteomic analysis revealed enrichment in pathways related to lipid transport, immune regulation, and vesicle-mediated processes. Overall, GBA1-PD patients share a distinct lipidomic EV signature, with mutation-specific patterns reflecting differing mechanisms of lysosomal dysfunction. These findings support the potential of EV profiling to unravel disease heterogeneity and identify biomarkers. Full article
(This article belongs to the Special Issue New Challenges of Parkinson’s Disease, 2nd Edition)
Show Figures

Figure 1

Back to TopTop